首页> 外文期刊>Biological trace element research >Serum Magnesium and Fractional Exhaled Nitric Oxide in Relation to the Severity in Asthma-Chronic Obstructive Pulmonary Disease Overlap
【24h】

Serum Magnesium and Fractional Exhaled Nitric Oxide in Relation to the Severity in Asthma-Chronic Obstructive Pulmonary Disease Overlap

机译:血清镁和分数呼出的一氧化氮,相对于哮喘 - 慢性阻塞性肺病的严重程度重叠

获取原文
获取原文并翻译 | 示例
           

摘要

Serum concentrations of magnesium and manganese may be associated with increased chronic obstructive pulmonary disease exacerbation risk. However, associations with other aspects of asthma-chronic obstructive pulmonary disease overlap, pulmonary function test results and health status, have been studied less extensively. The aim of this study was to investigate the associations between serum concentrations of trace elements and T lymphocyte subsets, FeNO, and COPD-related questionnaire scores in individuals with ACO and the potential impact of these parameters on lung function. All the patients met the diagnostic criteria of ACO and were divided into two groups (group A, mild-moderate; group B, severe-very severe) by their specific characteristics. Pulmonary function testing and serum Mg and serum Mn and FeNO were measured. Four hundred sixty-five patients were screened, and 42 were included. Group A had significantly higher Mg and Fe concentrations than group B. No significant differences were seen in the serum concentration of any other trace element between the two groups. Serum Mg and Mn were correlated with FEV1 % predicted (p < 0.01). Group A had a significantly higher FeNO concentration than group B (p = 0.005). The scores on CAT (p = 0.011) and mMRC (p = 0.008) in group A were lower than in group B. The low-FeNO group had a significantly lower concentration of serum Mg than the high-FeNO group (p = 0.03). Pulmonary function declined faster (p < 0.05) in the low-FeNO group than the high-FeNO group. Serum Mg concentration may indicate protective effects against lung function loss in ACO. This implies that FeNO might be a biomarker for identifying individuals with ACO who might benefit from inhaled corticosteroid therapy. Serum Mg and FeNO were associated with ACO severity. However, their role in guiding personalised treatment of individuals with ACO needs to be further investigated.
机译:血清镁和锰浓度可能与慢性阻塞性肺疾病恶化风险增加有关。然而,与哮喘、慢性阻塞性肺疾病、肺功能测试结果和健康状况的其他方面相关的研究较少。本研究的目的是调查ACO患者血清微量元素浓度与T淋巴细胞亚群、FeNO和COPD相关问卷得分之间的相关性,以及这些参数对肺功能的潜在影响。所有患者均符合ACO的诊断标准,并根据其具体特征分为两组(A组,轻度-中度;B组,重度-非常重度)。测定肺功能、血清镁、血清锰和FeNO。共筛查了465名患者,包括42名患者。A组的镁和铁浓度显著高于B组。两组之间任何其他微量元素的血清浓度均无显著差异。血清镁和锰与预测的FEV1%相关(p<0.01)。A组的FeNO浓度显著高于B组(p=0.005)。A组的CAT(p=0.011)和mMRC(p=0.008)得分低于B组。低FeNO组的血清镁浓度显著低于高FeNO组(p=0.03)。与高FeNO组相比,低FeNO组肺功能下降更快(p<0.05)。血清镁浓度可能表明ACO对肺功能丧失有保护作用。这意味着FeNO可能是识别ACO患者的生物标志物,这些患者可能受益于吸入糖皮质激素治疗。血清镁和FeNO与ACO严重程度相关。然而,他们在指导ACO患者个性化治疗中的作用需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号